COMBINATION TREATMENT WITH t-PA VARIANT AND LOW MOLECULAR WEIGHT HEPARIN

• 1. 重建人t－PA分子及表达重建人t－PA蛋白的工程菌株 [P] . 中国专利： CN1281048A . 2001-01-24
• 2. 用于治疗癌症的联合治疗组合物和联合治疗方法 [P] . 中国专利： CN112546230A . 2021-03-26
• 3. Combination Treatment with t-PA Variant and Low Molecular Weight Heparin [P] . 美国专利： US2009004177A1 . 2009-01-01

  机译： t-PA变异体和低分子量肝素的联合治疗

• 4. Combination Treatment with t-PA Variant And Low Molecular Weight Heparin [P] . 韩国专利： KR100831770B1 . 2008-05-27

  机译： t-PA变体和低分子量肝素联合治疗

• 5. Combination treatment with t-PA variant and low molecular weight heparin [P] . 美国专利： US7084118B2 . 2006-08-01

  机译： t-PA变异体和低分子量肝素的联合治疗

• 1. Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE [J] . CHEN Li-ying, YING Ke-jing, HONG Wu-jun, 浙江大学学报（英文版）（B辑：生物医学和生物技术） . 2005,第012期
• 2. Combined effect of Traditional Chinese Medicine decoction and low-molecular-weight heparin calcium on the postoperative deep venous thrombosis in patients with lower limb fracture [J] . 张惠煊, 马翰斐, 袁杰 世界中西医结合杂志（英文） . 2015,第001期
• 3. Efficacy and Safety of Low Molecular Weight Heparin Prophylaxis for Venous Thromboembolism Following Lumbar Decompression Surgery [J] . Zhi-jian Sun, Xiang Li, Yu Zhao, 中国医学科学杂志（英文版） . 2011,第004期
• 4. Astrocytic effect of low molecular weight heparin-superoxide dismutase conjugate in interleukin-6 overexpressing mice following local cerebral ischemia [J] . Yizhao Li, Guixiang Cui, Qingde Wang, 中国神经再生研究（英文版） . 2009,第002期
• 5. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis [J] . H Uncu Phlebology . 2009,第2期
• 6. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis. [J] . Uncu H Phlebology . 2009,第2期
• 7. Combinations of Low Doses of Unfractionated Heparin and of Low-Molecular-Weight Heparin Prevent Experimental Venous Thrombosis [J] . Guareide Carelli, Francisco H.A. Maffei, Luci Mattar, Pathophysiology of haemostasis and thrombosis . 2006,第6期
• 8. Treatment of PNH hemolytic crisis with heparin or low-molecular weight heparin by its dual (anti-complement and anti-coagulant) activity [C] . Chikashi YOSHIDA, Yasushi OHKOSHI, Yuichi HASEGAWA, International Symposium on PNH and Related Disorders . 2003
• 9. Surimi wash water treatment by chitosan-alginate complexes: Effect of molecular weight and degree of deacetylation of chitosan and nutritional evaluation of solids recovered by the treatment. [D] . Wibowo, Singgih. 2004
• 10. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): Preliminary in vivo evaluation of efficacy and toxicity using a canine model [O] . Li-Chien Chang, Shirley Wrobleski, Thomas W. Wakefield, 2001
• 11. The combination of LMWH (Low-Molecular-Weight Heparin) and Aspirin as a prophylaxis treatment for pre-eclampsia and SGA (Small-for-Gestational Age) neonates in medium- and high-risk women: protocol for a Systematic Review and Meta-Analysis. v1 (protocols.io.bhdtj26n) [O] . Christos Georgios, Georgios Mitsiakos, Dimitra Gialamprinou 2020

• 1. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin [J] . Cui HF ,Jiang XL . 世界胃肠病学杂志：英文版 . 1999,第5期
• 2. 小剂量尿激酶与低分子肝素钠联合治疗老年高龄急性冠状动脉综合征的疗效分析 [C] . 梁棕 ,梁转合 . 2012北京协和急诊医学国际高峰论坛 . 2012
• 3. MMP-1与t-PA联合治疗兔增生性玻璃体视网膜病变的实验研究 [A] . 戴昳宁 . 2006